VERO · Venus Concept Inc.
Going-concern doubt
— flagged Nov 13, 2025
Substantial doubt about the company's ability to continue as a going concern.
“The Company's recurring losses from operations and negative cash flows raise substantial doubt about the Company's ability to continue as a going concern within 12 months from the date that the condensed consolidated financial statements are issued.”View the 10-Q filed Nov 13, 2025
Market Cap
$578,187
Shares
1.86M
No Price Data
No daily price data is available for this stock yet. Data syncs automatically from Yahoo Finance.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Nov 13, 2025
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Limited
Momentum
Limited
Sentiment
Neutral
Fundamentals
Poor
Quant / Vol
Limited
Market backdrop
VIX 14.3 · calm
Equity put/call 0.52
Technical
price trend
Not enough data for a confident read.
Momentum
relative strength
Not enough data for a confident read.
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Distributing
-10% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.72% of float · ▼ -5.2% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
9 holders — near 3-yr low, contrarian setup
Fundamentals
Revenue growth
−15%
Y/Y
Gross margin
68%
expanding
EPS growth
−4%
Y/Y
Free cash flow
$-11.2M
Balance sheet
$27.2M
net debt
Quant / Vol
risk profile
Not enough data for a confident read.
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Prior guidance
period ended
· from the Earnings Call filed Jun 30, 2024
Total revenue
· three months ending September 30th 2024
at least $17M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
VERO
this stock
Venus Concept Inc.
|
$578,187 | — | -15.1% | — | 0.7% |
|
ABT
Abbott Laboratories
|
$194.07B | -11.2% | +5.7% | 31.2 | 1.3% |
|
SYK
Stryker Corp
|
$133.18B | -3.5% | +11.2% | 36.0 | 2.2% |
|
MDT
Medtronic plc
|
$116.83B | -5.0% | +8.4% | 24.5 | 1.4% |
|
BSX
Boston Scientific Corp
|
$75.11B | -45.6% | +12.5% | 21.0 | 1.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events